The company exhibits severe financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. With a Current Ratio of 0.54 and a Quick Ratio of 0.30, Roadzen faces a critical liquidity crisis and is unable to cover its short-term obligations. While the company shows positive revenue growth (18.80% YoY) and a strong gross margin (60.93%), these are completely offset by negative profit margins and a negative Price-to-Book ratio (-0.39), suggesting negative shareholder equity. The combination of a 0/100 technical trend and catastrophic health scores points toward a high risk of insolvency.